Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.

In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the expansion of its LV Edge System with the launch of a fully stable cell line development ...

Emily Whitehead made the history books in 2012 when she become the first pediatric patient with B-cell acute lymphoblastic leukemia to be given a chimeric antigen receptor (CAR) T-cell therapy. After ...